PubRank

Sapna Syngal

Author PubWeight™ 129.32‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004 14.97
2 ATM mutations in patients with hereditary pancreatic cancer. Cancer Discov 2011 3.27
3 American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers. J Clin Oncol 2014 3.07
4 Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history. JAMA 2004 2.99
5 Health benefits and cost-effectiveness of primary genetic screening for Lynch syndrome in the general population. Cancer Prev Res (Phila) 2010 2.86
6 Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome. Gastroenterology 2009 2.75
7 Prediction of MLH1 and MSH2 mutations in Lynch syndrome. JAMA 2006 2.73
8 Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology 2012 2.69
9 Evaluation of microsatellite instability and immunohistochemistry for the prediction of germ-line MSH2 and MLH1 mutations in hereditary nonpolyposis colon cancer families. Cancer Res 2002 2.33
10 Risk of pancreatic cancer in families with Lynch syndrome. JAMA 2009 2.32
11 Mutant GNAS detected in duodenal collections of secretin-stimulated pancreatic juice indicates the presence or emergence of pancreatic cysts. Gut 2012 2.17
12 A hereditary nonpolyposis colorectal carcinoma case associated with hypermethylation of the MLH1 gene in normal tissue and loss of heterozygosity of the unmethylated allele in the resulting microsatellite instability-high tumor. Cancer Res 2002 2.07
13 Pancreatic cancer genetic epidemiology consortium. Cancer Epidemiol Biomarkers Prev 2006 2.04
14 Obesity increases the risks of diverticulitis and diverticular bleeding. Gastroenterology 2008 2.01
15 Mutant TP53 in duodenal samples of pancreatic juice from patients with pancreatic cancer or high-grade dysplasia. Clin Gastroenterol Hepatol 2012 1.99
16 Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study. Lancet Oncol 2010 1.98
17 The PREMM(1,2,6) model predicts risk of MLH1, MSH2, and MSH6 germline mutations based on cancer history. Gastroenterology 2010 1.88
18 Physician assessment of family cancer history and referral for genetic evaluation in colorectal cancer patients. Clin Gastroenterol Hepatol 2004 1.76
19 Underutilization of BRCA1/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk. Genet Med 2011 1.70
20 Microsatellite instability and DNA mismatch repair protein deficiency in Lynch syndrome colorectal polyps. Cancer Prev Res (Phila) 2012 1.65
21 Human urine contains small, 150 to 250 nucleotide-sized, soluble DNA derived from the circulation and may be useful in the detection of colorectal cancer. J Mol Diagn 2004 1.62
22 Development and validation of a colon cancer risk assessment tool for patients undergoing colonoscopy. Am J Gastroenterol 2009 1.62
23 Knowledge of quality performance measures associated with endoscopy among gastroenterology trainees and the impact of a web-based intervention. Gastrointest Endosc 2012 1.59
24 Risk factors for mortality in lower intestinal bleeding. Clin Gastroenterol Hepatol 2008 1.55
25 Gynecologic cancer as a "sentinel cancer" for women with hereditary nonpolyposis colorectal cancer syndrome. Obstet Gynecol 2005 1.50
26 Chromoendoscopy detects more adenomas than colonoscopy using intensive inspection without dye spraying. Cancer Prev Res (Phila) 2008 1.47
27 Aberrant DNA methylation in hereditary nonpolyposis colorectal cancer without mismatch repair deficiency. Gastroenterology 2010 1.46
28 Nut, corn, and popcorn consumption and the incidence of diverticular disease. JAMA 2008 1.46
29 The comprehensiveness of family cancer history assessments in primary care. Community Genet 2007 1.42
30 Impact of preoperative staging and chemoradiation versus postoperative chemoradiation on outcome in patients with rectal cancer: a decision analysis. J Natl Cancer Inst 2004 1.42
31 Hereditary colorectal cancer syndromes. Cancer Causes Control 2005 1.40
32 Factors associated with enrollment in cancer genetics research. Cancer Epidemiol Biomarkers Prev 2006 1.31
33 Hereditary pancreatic cancer. Gastroenterology 2010 1.31
34 Cancer risk assessment: quality and impact of the family history interview. Am J Prev Med 2004 1.30
35 Timing of colonoscopy: impact on length of hospital stay in patients with acute lower intestinal bleeding. Am J Gastroenterol 2003 1.28
36 Colorectal cancers with microsatellite instability display unique miRNA profiles. Clin Cancer Res 2011 1.27
37 F18-fluorodeoxyglucose-positron emission tomography/computed tomography screening in Li-Fraumeni syndrome. JAMA 2008 1.26
38 Sharing genetic test results in Lynch syndrome: communication with close and distant relatives. Clin Gastroenterol Hepatol 2008 1.20
39 Early predictors of severity in acute lower intestinal tract bleeding. Arch Intern Med 2003 1.19
40 Phenotype comparison of MLH1 and MSH2 mutation carriers in a cohort of 1,914 individuals undergoing clinical genetic testing in the United States. Cancer Epidemiol Biomarkers Prev 2008 1.16
41 Validation and extension of the PREMM1,2 model in a population-based cohort of colorectal cancer patients. Gastroenterology 2007 1.16
42 Elevated risk of prostate cancer among men with Lynch syndrome. J Clin Oncol 2013 1.14
43 Comprehensive molecular analysis of mismatch repair gene defects in suspected Lynch syndrome (hereditary nonpolyposis colorectal cancer) cases. Cancer Res 2009 1.14
44 Enhanced retrieval of DNA from human fecal samples results in improved performance of colorectal cancer screening test. J Mol Diagn 2004 1.11
45 Missed adenomas during colonoscopic surveillance in individuals with Lynch Syndrome (hereditary nonpolyposis colorectal cancer). Cancer Prev Res (Phila) 2008 1.11
46 Determinants of colorectal cancer screening in women undergoing mammography. Am J Gastroenterol 2003 1.10
47 Colorectal cancer in young adults. Dig Dis Sci 2014 1.08
48 Prevalence of early onset colorectal cancer in 397 patients with classic Li-Fraumeni syndrome. Gastroenterology 2006 1.08
49 Recurrence and variability of germline EPCAM deletions in Lynch syndrome. Hum Mutat 2011 1.07
50 Inherited colorectal cancer syndromes. Cancer J 2011 1.06
51 Gastric cancer in individuals with Li-Fraumeni syndrome. Genet Med 2011 1.05
52 Validation of a clinical prediction rule for severe acute lower intestinal bleeding. Am J Gastroenterol 2005 1.04
53 Prevalence and predictors of appropriate colorectal cancer surveillance in Lynch syndrome. Am J Gastroenterol 2010 1.03
54 The impact of family history of diabetes on glucose testing and counseling behavior in primary care. Diabetes Care 2004 1.02
55 Genetic testing in gastroenterology: Lynch syndrome. Best Pract Res Clin Gastroenterol 2009 1.02
56 Comparison of the clinical prediction model PREMM(1,2,6) and molecular testing for the systematic identification of Lynch syndrome in colorectal cancer. Gut 2012 0.99
57 Colon cancer screening strategies. Curr Opin Gastroenterol 2005 0.98
58 Predictors of utilization of early colonoscopy vs. radiography for severe lower intestinal bleeding. Gastrointest Endosc 2005 0.98
59 Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry. JAMA Oncol 2015 0.96
60 Colorectal cancer risk perception on the basis of genetic test results in individuals at risk for Lynch syndrome. J Clin Oncol 2009 0.96
61 Colorectal cancer screening: prevalence among low-income groups with health insurance. Health Aff (Millwood) 2009 0.96
62 Recently identified colon cancer predispositions: MYH and MSH6 mutations. Semin Oncol 2007 0.94
63 Impact of genetic testing on endometrial cancer risk-reducing practices in women at risk for Lynch syndrome. Gynecol Oncol 2012 0.94
64 Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the U.S. Multi-Society Task Force on Colorectal Cancer. Gastrointest Endosc 2014 0.94
65 Intraductal papillary mucinous neoplasm of the pancreas with loss of mismatch repair in a patient with Lynch syndrome. Am J Surg Pathol 2009 0.94
66 Risk assessment, genetic testing, and management of Lynch syndrome. J Natl Compr Canc Netw 2010 0.92
67 Screening patients with colorectal cancer for Lynch syndrome: what are we waiting for? J Clin Oncol 2012 0.92
68 Attitudes toward prenatal genetic testing in patients with familial adenomatous polyposis. Am J Gastroenterol 2007 0.90
69 Performance of PREMM(1,2,6), MMRpredict, and MMRpro in detecting Lynch syndrome among endometrial cancer cases. Genet Med 2012 0.87
70 Racial and ethnic variations in the effects of family history of colorectal cancer on screening compliance. Gastroenterology 2013 0.86
71 Clinical presentation correlates with the type of mismatch repair gene involved in hereditary nonpolyposis colon cancer. Gastroenterology 2004 0.86
72 Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on Colorectal Cancer. Dis Colon Rectum 2014 0.85
73 Colorectal cancer screening awareness and intentions among low income, sociodemographically diverse adults under age 50. Cancer Causes Control 2008 0.85
74 Identification of germline genomic copy number variation in familial pancreatic cancer. Hum Genet 2012 0.85
75 Prediction models in Lynch syndrome. Fam Cancer 2013 0.84
76 Correlation of polyp number and family history of colon cancer with germline MYH mutations. Clin Gastroenterol Hepatol 2005 0.84
77 Data reduction for prediction: a case study on robust coding of age and family history for the risk of having a genetic mutation. Stat Med 2007 0.83
78 Adenomas in young patients: what is the optimal evaluation? Am J Gastroenterol 2005 0.81
79 Linkage analysis of chromosome 4 in families with familial pancreatic cancer. Cancer Biol Ther 2007 0.80
80 Recurrences are common after endoscopic ampullectomy for adenoma in the familial adenomatous polyposis (FAP) syndrome. Surg Endosc 2014 0.80
81 Clinical guidelines versus universal molecular testing: are we ready to choose an optimal strategy for Lynch syndrome identification? Am J Gastroenterol 2008 0.80
82 Multivitamin use among multi-ethnic, low-income adults. Cancer Causes Control 2009 0.79
83 An American founder mutation in MLH1. Int J Cancer 2011 0.79
84 Dysplasia in Barrett esophagus. Cancer 2004 0.78
85 One less thing to worry about: the shrinking spectrum of tumors in BRCA founder mutation carriers. J Natl Cancer Inst 2004 0.78
86 Attitudes toward childbearing and prenatal testing in individuals undergoing genetic testing for Lynch syndrome. Fam Cancer 2011 0.77
87 Screening for germline mismatch repair mutations following diagnosis of sebaceous neoplasm. JAMA Dermatol 2014 0.76
88 Universal Screening for Mismatch-Repair Deficiency in Endometrial Cancers to Identify Patients With Lynch Syndrome and Lynch-like Syndrome. Int J Gynecol Pathol 2017 0.76
89 Gastropericardial fistula-induced pericarditis: an unusual consequence of GERD. Medscape J Med 2008 0.75
90 Rectal mucosal quantitative galactose oxidase-Schiff reaction as an early detection biomarker for colorectal cancer: comparison to fecal occult stool blood test. Cancer Biomark 2011 0.75
91 Changes in colorectal cancer screening intention among people aged 18-49 in the United States. BMC Public Health 2014 0.75
92 Comprehensive genetic and endoscopic evaluation may be necessary to distinguish sporadic versus familial adenomatous polyposis-associated abdominal desmoid tumors. Surgery 2004 0.75
93 Genetic testing for hereditary nonpolyposis colorectal cancer. Curr Opin Gastroenterol 2003 0.75
94 Colon cancer screening strategies. Curr Opin Gastroenterol 2002 0.75